A
-
Antigen Quantitation
Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
-
APRI
The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study [2.1, Issue 1, 2016, Pages 1-8]
C
-
Cellular carcinoma
Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
-
Chronic hepatitis B
Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
-
Chronic hepatitis C
The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study [2.1, Issue 1, 2016, Pages 1-8]
-
Chronic hepatitis C
Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
F
-
FIB-4
The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study [2.1, Issue 1, 2016, Pages 1-8]
-
FibroScan
The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study [2.1, Issue 1, 2016, Pages 1-8]
-
FibroScan
Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
G
-
Genotype 4
Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
H
-
Hepatitis B Surface
Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
-
Hepatitis C virus
Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
-
Hepatitis C Virus Genotype 4
Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
-
Hyaluronic acid
Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
-
Hyaluronic acid vascular
Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
L
-
Liver Biopsy
Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
-
Liver fibrosis
Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
R
-
Ribavirin
Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
S
-
Score
Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
-
Sofosbuvir plus
Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
T
-
Transient elastography
Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
-
Treatment-naïve
Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
-
Treatment response
Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
V
-
Vascular endothelial growth
Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
Your query does not match with any item